Background And Aims: Cervical spondylosis (CS) is reported to be associated with increased sympathetic activity and hypertension. However, the cardiovascular (CV) outcomes of patients with CS are largely unknown.
Methods: A national insurance claims dataset of 22 million enrollees in Taiwan during 1999-2010 was used as the research database. We identified 27,948 patients with CS and age-, sex-, and comorbidity-matched controls. By using multivariate logistic regression analysis after adjustment for potential cardiovascular (CV) confounders, we calculated odds ratios (ORs) with 95% confidence intervals (CIs) to quantify the association between CS and acute coronary syndrome (ACS).
Results: A total of 744 ACS events were identified among the 27,948 patients with CS. The overall incidence of ACS was 4.27 per 1000 person-years in the CS cohort and 3.90 per 1000 person-years in the non-CS cohort, with an adjusted hazard ratio (aHR) of 1.13 (95% CI = 1.08-1.18). The aHRs of ACS were 1.08 (95% CI = 1.03-1.15) in the CS cohort without myelopathy and 1.20 (95% CI = 1.13-1.28) in the CS cohort with myelopathy, compared with the non-CS cohort. Compared with patients with CS without neurological signs, patients with CS receiving rehabilitation exhibited a 0.67 aHRs of ACS (95% CI = 0.59-0.76), whereas those with neurological signs receiving spinal decompression exhibited 0.73 aHRs of ACS (95% CI = 0.63-0.84).
Conclusions: CS is associated with an increased risk of ACS. Receiving treatment for CS, either rehabilitation or spinal decompression, is associated with less risk of ACS.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.atherosclerosis.2018.02.029 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Incidence and outcomes of transient new-onset atrial fibrillation complicating acute coronary syndromes: results from a systematic review and meta-analysis.
Eur Heart J Cardiovasc Pharmacother
October 2024
Department of Experimental and Clinical Medicine, Magna Graecia University, Viale Europa, 88100Catanzaro, Italy.
Article Synopsis
- A meta-analysis was conducted to evaluate the long-term risks of transient new-onset atrial fibrillation (AF) in patients who experienced acute coronary syndrome (ACS), finding a significant association with adverse outcomes.
- The study included seven observational studies with over 151,700 patients, showing that transient new-onset AF notably increased the risk of ischemic stroke, recurrent AF, and all-cause mortality, with hazard ratios indicating substantial risks for these conditions.
- The findings suggest that patients with transient new-onset AF following ACS may benefit from closer monitoring and the potential use of oral anticoagulants to mitigate risks, highlighting the need for further randomized controlled trials.
Comparison of effectiveness and safety between ticagrelor and clopidogrel in patients with acute coronary syndrome and on dialysis in Taiwan.
Br J Clin Pharmacol
January 2022
School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.
Aims: This study aimed to evaluate and compare the effectiveness and safety between clopidogrel and ticagrelor in acute coronary syndrome (ACS) with renal dysfunction.
Methods: We conducted a retrospective cohort study on patients on chronic dialysis and whose admission diagnosis between 1 July 2013 and 31 December 2016 included ACS. The primary effectiveness endpoint was a major adverse cardiovascular event (MACE), and the primary safety endpoint was a major bleeding event.
Joint Longitudinal Low Calcium High Phosphorus Trajectory Associates with Accelerated Progression, Acute Coronary Syndrome and Mortality in Chronic Kidney Disease.
Sci Rep
June 2020
Division of Nephrology, Department of Internal Medicine, China Medical University Hospital and College of Medicine, China Medical University, Taichung, Taiwan.
The effects of long-term disturbance of the mineral metabolism on patients with chronic kidney disease (CKD) are unclear. We investigated whether the longitudinal Ca-P (joint calcium and phosphorus) trajectories are associated with incident end-stage renal disease (ESRD), acute coronary syndrome (ACS), and all-cause mortality in patients with CKD. We conducted a prospective cohort study by using data from a 13-year multidisciplinary pre-ESRD care registry.
View Article and Find Full Text PDFHigh-frequency metabolite profiling and the incidence of recurrent cardiac events in patients with post-acute coronary syndrome.
Biomarkers
May 2020
Department of Cardiology, Erasmus University Medical Centre (Erasmus MC), Rotterdam, the Netherlands.
The aim of this study was to study temporal changes in metabolite profiles in patients with post-acute coronary syndrome (ACS), in particular prior to the development of recurrent ACS (reACS). BIOMArCS (BIOMarker study to identify the Acute risk of a Coronary Syndrome) is a prospective study including patients admitted for ACS, who underwent high-frequency blood sampling during 1-year follow-up. Within BIOMArCS, we performed a nested case-cohort analysis of 158 patients (28 cases of reACS).
View Article and Find Full Text PDFBarriers to Healthcare Access and Long-Term Survival After an Acute Coronary Syndrome.
J Gen Intern Med
September 2018
Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, USA.
Background: Barriers to healthcare are common in the USA and may result in worse outcomes among hospital survivors of an acute coronary syndrome (ACS).
Objective: To examine the relationship between barriers to healthcare and 2-year mortality after hospital discharge for an ACS.
Design: Longitudinal study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!